CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ³ëÁ¾·Ä
  • °©»ó¼±¾Ï¼¾ÅÍÀå
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : µÎ°æºÎ¾Ï,°©»ó¼±¼ö¼ú,¸ñÁúȯ,À½¼ºÀå¾Ö,³»½Ã°æ-·Îº¿¼ö¼ú
  • Á÷ À§: ±³¼ö(°©»ó¼±¾Ï¼¾ÅÍÀå)
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

µî·Ï

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ ´Ù¿î·Îµå
312 ÇØ¿Ü Lee J, You JH, Kim MS, Roh JL. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer. Redox Biol. 2020 Aug 28;37:101697. [Online ahead of print.] (Corresponding author)  
311 ÇØ¿Ü Shin CH, Roh JL, Song DE, Cho KJ, Choi SH, Nam SY, Kim SY. Prognostic value of tumor size and minimal extrathyroidal extension in papillary thyroid carcinoma. Am J Surg. 2020 Feb 16:S0002-9610(20)30089-1. [Online ahead of print.] (Corresponding author)  
310 ÇØ¿Ü Jung AR, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY. The impact of skeletal muscle depletion on older adult patients with head and neck Cancer undergoing primary surgery. J Geriatr Oncol. 2020 Jun 18:S1879-4068(20)30093-X. [Online ahead of print.] (Corresponding author)  
309 ÇØ¿Ü Kim Y, Roh JL, Song D, Cho KJ, Choi SH, Nam SY, Kim SY. Predictors of recurrence after total thyroidectomy plus neck dissection and radioactive iodine ablation for high-risk papillary thyroid carcinoma. J Surg Oncol. 2020 Jun 25. [Online ahead of print.] (Corresponding author)  
308 ÇØ¿Ü Bae MR, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY. Prediction of cervical metastasis and survival in cN0 oral cavity cancer using tumour 18F-FDG PET/CT functional parameters. J Cancer Res Clin Oncol. 2020 Jul 8. [Online ahead of print.] (Corresponding author)  
307 ÇØ¿Ü Lee J, You JH, Shin D, Roh JL. Ex vivo culture of head and neck cancer explants in cell sheet for testing chemotherapeutic sensitivity. J Cancer Res Clin Oncol. 2020 Oct;146(10):2497-2507. (Corresponding author)  
306 ÇØ¿Ü Lee H, Roh JL, Cho KJ, Choi SH, Nam SY, Kim SY. Positive lymph node number and extranodal extension for predicting recurrence and survival in patients with salivary gland cancer. Head Neck. 2020 Aug;42(8):1994-2001. (Corresponding author)  
305 ÇØ¿Ü Jung AR, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY. Post-treatment 18F-FDG PET/CT for predicting survival and recurrence in patients with advanced-stage head and neck cancer undergoing curative surgery. Oral Oncol. 2020 Aug;107:104750. (Corresponding author)  
304 ÇØ¿Ü Ku JY, Roh JL, Cho KJ, Song JS, Choi SH, Nam SY, Kim SY. Risk factors for survival of head and neck soft tissue sarcomas: A comparison between 7th and 8th edition AJCC staging systems. Oral Oncol. 2020 Jul;106:104705. (Corresponding author)  
303 ÇØ¿Ü Lee J, You JH, Shin D, Roh JL. Inhibition of glutaredoxin 5 predisposes cisplatin-resistant head and neck cancer cells to ferroptosis. Theranostics. 2020 Jun 19;10(17):7775-7786. (Corresponding author)  
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 6 7 8 9 10 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729